These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 34747190)

  • 1. The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.
    Malek AE; Cornejo PP; Daoud N; Alam M
    Immunotherapy; 2022 Feb; 14(2):91-94. PubMed ID: 34747190
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications for and contraindications of immune checkpoint inhibitors in cancer patients with COVID-19 vaccination.
    Luo B; Li J; Hou X; Yang Q; Zhou Y; Ye J; Wu X; Feng Y; Hu T; Xu Z; He Y; Sun J
    Future Oncol; 2021 Sep; 17(26):3477-3484. PubMed ID: 34189948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis.
    Molica S; Giannarelli D; Montserrat E
    Eur J Haematol; 2022 Mar; 108(3):264-267. PubMed ID: 34856031
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
    Silvestris N
    EBioMedicine; 2021 Dec; 74():103733. PubMed ID: 34864362
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 Vaccination Imperatives in People on Maintenance Dialysis: An International Perspective.
    Blake PG; Hladunewich MA; Oliver MJ
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1746-1748. PubMed ID: 34281983
    [No Abstract]   [Full Text] [Related]  

  • 6. Three, four or more: what's the magic number for booster shots?
    Watson C
    Nature; 2022 Feb; 602(7895):17-18. PubMed ID: 35091715
    [No Abstract]   [Full Text] [Related]  

  • 7. Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors.
    Waissengrin B; Agbarya A; Safadi E; Padova H; Wolf I
    Lancet Oncol; 2021 May; 22(5):581-583. PubMed ID: 33812495
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.
    Korang SK; von Rohden E; Veroniki AA; Ong G; Ngalamika O; Siddiqui F; Juul S; Nielsen EE; Feinberg JB; Petersen JJ; Legart C; Kokogho A; Maagaard M; Klingenberg S; Thabane L; Bardach A; Ciapponi A; Thomsen AR; Jakobsen JC; Gluud C
    PLoS One; 2022; 17(1):e0260733. PubMed ID: 35061702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 10. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations.
    Abid MB
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.
    Cooper DM; Afghani B; Byington CL; Cunningham CK; Golub S; Lu KD; Radom-Aizik S; Ross LF; Singh J; Smoyer WE; Lucas CT; Tunney J; Zaldivar F; Ulloa ER
    Pediatr Res; 2021 Nov; 90(5):966-970. PubMed ID: 33627824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
    Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

  • 14. Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.
    Barrière J; Carles M; Audigier-Valette C; Re D; Adjtoutah Z; Seitz-Polski B; Gounant V; Descamps D; Zalcman G
    Eur J Cancer; 2022 Feb; 162():182-193. PubMed ID: 35016032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses.
    Wisnewski AV; Liu J; Lucas C; Klein J; Iwasaki A; Cantley L; Fazen L; Campillo Luna J; Slade M; Redlich CA
    PLoS One; 2022; 17(1):e0262657. PubMed ID: 35041700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine breakthrough infections.
    Gupta RK; Topol EJ
    Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccination and cancer immunotherapy: should they stick together?
    Brest P; Mograbi B; Hofman P; Milano G
    Br J Cancer; 2022 Jan; 126(1):1-3. PubMed ID: 34799696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine trials must include helminth-infected cohorts.
    Egwang TG; Owalla TJ; Kemigisha M
    Nat Immunol; 2022 Feb; 23(2):148. PubMed ID: 35075281
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccination for children: may be necessary for the full eradication of the disease.
    Praticò AD; Ruggieri M
    Pediatr Res; 2021 Dec; 90(6):1102-1103. PubMed ID: 34253861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.